Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors

Human pluripotent stem cells (PSC) have been used for disease modelling, after differentiation into the desired cell type. Electrophysiologic properties of cardiomyocytes derived from pluripotent stem cells are extensively used to model cardiac arrhythmias, in cardiomyopathies and channelopathies. This requires strict control of the multiple variables that can influence the electrical properties of these cells. In this article, we report the action potential variability of 780 cardiomyocytes derived from pluripotent stem cells obtained from six healthy donors. We analyze the overall distribution of action potential (AP) data, the distribution of action potential data per cell line, per differentiation protocol and batch. This analysis indicates that even using the same cell line and differentiation protocol, the differentiation batch still affects the results. This variability has important implications in modeling arrhythmias and imputing pathogenicity to variants encountered in patients with arrhythmic diseases. We conclude that even when using isogenic cell lines to ascertain pathogenicity to variants associated to arrythmias one should use cardiomyocytes derived from pluripotent stem cells using the same differentiation protocol and batch and pace the cells or use only cells that have very similar spontaneous beat rates. Otherwise, one may find phenotypic variability that is not attributable to pathogenic variants

Toll-like Receptor 4 Activation Promotes Cardiac Arrhythmias By Decreasing The Transient Outward Potassium Current (ito) Through An Irf3-dependent And Myd88-independent Pathway

Cardiac arrhythmias are one of the main causes of death worldwide. Several studies have shown that inflammation plays a key role in different cardiac diseases and Toll-like receptors (TLRs) seem to be involved in cardiac complications. In the present study, we investigated whether the activation of TLR4 induces cardiac electrical remodeling and arrhythmias, and the signaling pathway involved in these effects. Membrane potential was recorded in Wistar rat ventricle. Ca2+ transients, as well as the L-type Ca2+ current (ICaL) and the transient outward K+ current (Ito), were recorded in isolated myocytes after 24h exposure to the TLR4 agonist, lipopolysaccharide (LPS, 1μg/ml). TLR4 stimulation in vitro promoted a cardiac electrical remodeling that leads to action potential prolongation associated with arrhythmic events, such as delayed afterdepolarization and triggered activity. After 24h LPS incubation, Ito amplitude, as well as Kv4.3 and KChIP2 mRNA levels were reduced. The Ito decrease by LPS was prevented by inhibition of interferon regulatory factor 3 (IRF3), but not by inhibition of interleukin-1 receptor-associated kinase 4 (IRAK4) or nuclear factor kappa B (NF-κB). Extrasystolic activity was present in 25% of the cells, but apart from that, Ca2+ transients and ICaL were not affected by LPS; however, Na+/Ca2+ exchanger (NCX) activity was apparently increased. We conclude that TLR4 activation decreased Ito, which increased AP duration via a MyD88-independent, IRF3-dependent pathway. The longer action potential, associated with enhanced Ca2+ efflux via NCX, could explain the presence of arrhythmias in the LPS group.767075Murray, C.J., Lopez, A.D., Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study (1997) Lancet, 349, pp. 1498-1504Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) (1994) Lancet, 344, pp. 1383-1389Algra, A., Tijssen, J.G., Roelandt, J.R., Pool, J., Lubsen, J., QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest (1991) Circulation, 83, pp. 1888-1894Casis, O., Gallego, M., Iriarte, M., Sánchez-Chapula, J.A., Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle (2000) Diabetologia, 43, pp. 101-109Kang, Y.J., Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death (2006) Toxicol Pathol, 34, pp. 58-66Leurs, R., Church, M.K., Taglialatela, M., H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects (2002) Clin Exp Allergy, 32, pp. 489-498Monnerat-Cahli, G., Trentin-Sonoda, M., Guerra, B., Manso, G., Ferreira, A.C., Silva, D.L., Bone marrow mesenchymal stromal cells rescue cardiac function in streptozotocin-induced diabetic rats (2013) Int J Cardiol, 171, pp. 199-208Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A., C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease (2004) N Engl J Med, 350, pp. 1387-1397Scheruebel, S., Koyani, C.N., Hallström, S., Lang, P., Platzer, D., Mächler, H., If blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes (2014) J Mol Cell Cardiol, 72, pp. 64-73Devaraj, S., Dasu, M.R., Rockwood, J., Winter, W., Griffen, S.C., Jialal, I., Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state (2008) J Clin Endocrinol Metab, 93, pp. 578-583Casey, L.C., Balk, R.A., Bone, R.C., Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome (1993) Ann Intern Med, 119, pp. 771-778Nozaki, N., Shishido, T., Takeishi, Y., Kubota, I., Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice (2004) Circulation, 110, pp. 2869-2874Shishido, T., Nozaki, N., Yamaguchi, S., Shibata, Y., Nitobe, J., Miyamoto, T., Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction (2003) Circulation, 108, pp. 2905-2910Fallach, R., Shainberg, A., Avlas, O., Fainblut, M., Chepurko, Y., Porat, E., Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia (2010) J Mol Cell Cardiol, 48, pp. 1236-1244Panama, B.K., Latour-Villamil, D., Farman, G.P., Zhao, D., Bolz, S.-S., Kirshenbaum, L.A., Nuclear factor κB downregulates the transient outward potassium current Ito, f through control of KChIP2 expressionnovelty and significance (2011) Circ Res, 108, pp. 537-543Medei, E.H., Nascimento, J.H., Pedrosa, R.C., Barcellos, L., Masuda, M.O., Sicouri, S., Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration (2008) Europace, 10, pp. 868-876Penna, L.B., Bassani, R.A., Increased spontaneous activity and reduced inotropic response to catecholamines in ventricular myocytes from footshock-stressed rats (2010) Stress, 13, pp. 73-82Bassani, R.A., Ricardo, R.A., Bassani, J.W., Estimation of the fractional sarcoplasmic reticulum Ca2+ release in intact cardiomyocytes using integrated Ca2+ fluxes (2012) Gen Physiol Biophys, 31, pp. 401-408Bassani, R.A., Bassani, J.W., Bers, D.M., Mitochondrial and sarcolemmal Ca2+ transport reduce [Ca2+]i during caffeine contractures in rabbit cardiac myocytes (1992) J Physiol, 453, pp. 591-608Voigt, N., Heijman, J., Wang, Q., Chiang, D.Y., Li, N., Karck, M., Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation (2014) Circulation, 129, pp. 145-156Boyd, J.H., Mathur, S., Wang, Y., Bateman, R.M., Walley, K.R., Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response (2006) Cardiovasc Res, 72, pp. 384-393Oyama, J., Blais, C., Liu, X., Pu, M., Kobzik, L., Kelly, R.A., Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice (2004) Circulation, 109, pp. 784-789Zheng, Z.J., Croft, J.B., Giles, W.H., Mensah, G.A., Sudden cardiac death in the United States, 1989 to 1998 (2001) Circulation, 104, pp. 2158-2163Friedman, R.A., Kearney, D.L., Moak, J.P., Fenrich, A.L., Perry, J.C., Persistence of ventricular arrhythmia after resolution of occult myocarditis in children and young adults (1994) J Am Coll Cardiol, 24, pp. 780-783Wondergem, R., Graves, B.M., Ozment-Skelton, T.R., Li, C., Williams, D.L., Lipopolysaccharides directly decrease Ca2+ oscillations and the hyperpolarization-activated nonselective cation current If in immortalized HL-1 cardiomyocytes (2010) Am J Physiol Cell Physiol, 299, pp. C665-C671Medei, E., Marocolo, M., Rodrigues, D., Arantes, P.C., Takiya, C.M., Silva, J., Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: cellular, ionic and molecular mechanism (2010) J Mol Cell Cardiol, 49, pp. 165-175Zhou, C., Ziegler, C., Birder, L.A., Stewart, A.F., Levitan, E.S., Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA (2006) Circ Res, 98, pp. 1040-1047Zhang, G., Ghosh, S., Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity (2001) J Clin Invest, 107, pp. 13-19Takeda, K., Akira, S., TLR signaling pathways (2004) Semin Immunol, 16, pp. 3-9Schlotthauer, K., Bers, D.M., Sarcoplasmic reticulum Ca(2+) release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials (2000) Circ Res, 87, pp. 774-780Ter Keurs, H.E., Boyden, P.A., Calcium and arrhythmogenesis (2007) Physiol Rev, 87, pp. 457-506Boer, D.C., Bassani, J.W., Bassani, R.A., Functional antagonism of β-adrenoceptor subtypes in the catecholamine-induced automatism in rat myocardium (2011) Br J Pharmacol, 162, pp. 1314-1325Carvalho, B.M., Bassani, R.A., Franchini, K.G., Bassani, J.W., Enhanced calcium mobilization in rat ventricular myocytes during the onset of pressure overload-induced hypertrophy (2006) Am J Physiol Heart Circ Physiol, 291, pp. H1803-H1813Pogwizd, S.M., Bers, D.M., Cellular basis of triggered arrhythmias in heart failure (2004) Trends Cardiovasc Med, 14, pp. 61-66Milberg, P., Pott, C., Fink, M., Frommeyer, G., Matsuda, T., Baba, A., Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3 (2008) Heart Rhythm, 5, pp. 1444-145